CAH vs. DXCM, HOLX, MMSI, AMN, COR, ELV, HAE, ITGR, MCK, and HSIC
Should you be buying Cardinal Health stock or one of its competitors? The main competitors of Cardinal Health include DexCom (DXCM), Hologic (HOLX), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Cencora (COR), Elevance Health (ELV), Haemonetics (HAE), Integer (ITGR), McKesson (MCK), and Henry Schein (HSIC). These companies are all part of the "medical" sector.
Cardinal Health vs. Its Competitors
Cardinal Health (NYSE:CAH) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends, earnings and media sentiment.
Cardinal Health has higher revenue and earnings than DexCom. Cardinal Health is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.
Cardinal Health has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.44, suggesting that its share price is 44% more volatile than the S&P 500.
87.2% of Cardinal Health shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 0.1% of Cardinal Health shares are owned by company insiders. Comparatively, 0.3% of DexCom shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
DexCom has a net margin of 12.90% compared to Cardinal Health's net margin of 0.70%. DexCom's return on equity of 30.05% beat Cardinal Health's return on equity.
Cardinal Health currently has a consensus price target of $157.43, indicating a potential downside of 6.08%. DexCom has a consensus price target of $98.50, indicating a potential upside of 18.85%. Given DexCom's stronger consensus rating and higher possible upside, analysts clearly believe DexCom is more favorable than Cardinal Health.
In the previous week, DexCom had 4 more articles in the media than Cardinal Health. MarketBeat recorded 31 mentions for DexCom and 27 mentions for Cardinal Health. DexCom's average media sentiment score of 1.29 beat Cardinal Health's score of 1.27 indicating that DexCom is being referred to more favorably in the news media.
Summary
DexCom beats Cardinal Health on 14 of the 17 factors compared between the two stocks.
Get Cardinal Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cardinal Health Competitors List
Related Companies and Tools
This page (NYSE:CAH) was last updated on 7/7/2025 by MarketBeat.com Staff
Free CAH Stock Alerts